Current Issue

Year 2019

Volume: 4 , Issue: 2

Print ISSN:-2581-5555

Online ISSN:-2456-9542

Member of


IP International Journal of Comprehensive and Advanced Pharmacology


Extemporaneous compounding: Cautions, controversies and convenience


Full Text PDF Share on Facebook Share on Twitter


Author Details: A K Mohiuddin*

Volume : 3

Issue : 4

Online ISSN : 2456-9542

Print ISSN : 2581-5555

Article First Page : 124

Article End Page : 137


Abstract

Pharmacists are only knowledgeable and skilled healthcare professionals dedicated to compounding and preparing medications to meet the unique needs of patients. The safe and effective extemporaneous compounding of prescription products for patients require in special care is fundamental to the pharmacy profession. But there are much to do for secundum artem. It is not at all economical for a pharmaceutical company to marketize a product in 10 different probable doses or in 5 different dosage forms to meet the needs of the entire range of individuals receiving therapy. Although development is a continuous process, companies are customizing features to meet the majority of patient needs, but the very nature of the process cannot meet all patient needs. The risk-benefit ratio of using traditionally compounded medicines is favorable for patients who require specialized medications that are not commercially available, as they would otherwise not have access to suitable treatment. However, if an FDA-approved drug is commercially available, the use of an unapproved compounded drug confers additional risk with no commensurate benefit. Published reports of independent testing by the FDA, state agencies, and others consistently show that compounded drugs fail to meet specifications at a considerably higher rate than FDA-approved drugs. Compounded sterile preparations pose the additional risk of microbial contamination to patients. In the last 11 years, three separate meningitis outbreaks have been traced to purportedly ‘sterile’ steroid injections contaminated with fungus or bacteria, which were made by compounding pharmacies. The 2012 outbreak has resulted in intense scrutiny of pharmacy compounding practices and increased recognition of the need to ensure that compounding is limited to appropriate circumstances.
Purpose of The Study: The article intends to physico-chemical and economic contemplations previously compounding; elements and quality control issues; compounding support, preparing, chemical supplies, kinds of compounding (exceptionally in hospital and walking care compounding). It should help to rehearse the unpremeditated readiness of fundamental and propelled definitions including pharmacopoeial and non-pharmacopoeial plans experienced in drug store practice, together with essential documentation, marking, bundling and directing prerequisites. Alongside this, they need to contemplate the investigation of definitions and their segments and relate these to the clinical execution of medicines. This will assist them with investigating, assess and report the physical attributes of details including discharge energy and relate these to quality control and pre-formulation prerequisites; relate the utilization of quality control, quality confirmation and the standards of good assembling practice to direction of medicine creation in home and abroad.
Outline: Background; Introduction; Compounding Factors; Types of Compounding; Identifying Errors and Cause.

Keywords: Pharmacy practice, Drugs, Dosage forms, Compounding, Equipment, Pharmacopeia.

Doi :-https://doi.org/10.18231/2456-9542.2018.0028